Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thromboxane A synthase 1 antisense RNA is a transcript generated from the opposite DNA strand of the TBXAS1 gene region. It is categorized as a long non-coding RNA (lncRNA), and its biological function, disease associations, and therapeutic relevance are not characterized in the scientific literature. All validated therapeutic targeting refers to the enzyme thromboxane A synthase 1, not to the antisense transcript. If a therapeutic target is intended, the correct entity is the protein-coding gene TBXAS1 and its enzyme product, which is involved in the biosynthesis of thromboxane A2, a mediator of platelet aggregation and vasoconstriction[1][3][5][7][9]. The Ensembl gene ID appears to be incorrect; the canonical TBXAS1 gene is ENSG00000059377, not ENSG00000305529[7].
None documented for the antisense transcript. Mechanisms for TBXAS1 enzyme inhibitors include inhibition of thromboxane A2 synthesis, leading to reduced platelet aggregation and vasoconstriction[1][3][7].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thromboxane A synthase 1 antisense RNA (None).